IMP: The Board resolution dated September 7, 2026
Filed with HOSE · · 8 pages · English and Vietnamese
Earlier from Imexpharm
- IMP: Report on Corporate Governance for the first half of 2026
- IMP: 2024 Annual Report
- IMP: 2023 Annual Report
- IMP: 2025 Annual Report
- IMP: Record date for 2025 cash dividend payment
Later from Imexpharm
- IMP: Update Regulations on Supervision and Approval of related party transactions
- IMP: Update Regulations on the Internal Audit
- IMP: Update Regulations on the Operation of the audit & Risk Management Committee
Follow Imexpharm into a list and get an email when it puts out news.
Follow Imexpharm